SHE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Shedir Pharma Srl Unipersonale

Watchlist Manager

Watchlist

Price: 4.88 EUR Market Closed

Market Cap: €55.8m

	Shedir Pharma Srl Unipersonale MIL:SHE	IT
	Leonteq AG F:EFL	CH
	Thomson Reuters Corp TSX:TRI	CA
Y	Yip's Chemical Holdings Ltd OTC:YIPCF	HK
	Industria de Diseno Textil SA MAD:ITX	ES
C	Coca-Cola Consolidated Inc F:CC5	US
	Multiconsult ASA OSE:MULTI	NO

Profitability Summary

Shedir Pharma Srl Unipersonale's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

60%

Gross Margin is Increasing

58% > 60%

Healthy Operating Margin

15%

Sustainable 3Y Average Operating Margin

14%

Declining Operating Margin

15% > 15%

Low Net Margin

10%

Low 3Y Average Net Margin

10%

Declining Net Margin

10% > 10%

Exceptional Free Cash Flow Margin

12%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-3% > 12%

Positive ROE

18%

Positive 3Y Average ROE

Positive 3Y Average ROIC

17%

Declining ROIC

23% > 18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.